Response assessment and treatment duration
Tumors, glioblastoma
GLIOBLASTOMA, DISEASE PROGRESSION, SOLID TUMORS, TUMORS
Response evaluation is performed every 8 weeks for the first 24 weeks and subsequently every 12 weeks until disease progression or treatment discontinuation. For patients with solid tumors other than glioblastoma response will be evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline v 1.1 [